IMVIF

0.00010.00%
SF

Stephan Fiset

Vice President of Clinical Research

Mr. Stephan Fiset, MSc, MBA serves as Vice President of Clinical Research at IMV Inc. (formerly known as ImmunoVaccine Inc.). since June 21, 2017. Mr. Fiset worked for certain years in clinical research with Medicago, GlaxoSmithKline and the Infectious Disease Research Center of the CHUL, where he led multifunctional teams in several therapeutic areas, including Oncology, HIV, Vaccines, Sepsis, Hematology and Neurology. Throughout his career, he was involved in scientific and operational activities of several Phase I to Phase III trials. He led several process improvement teams to ensure timely and cost-effective delivery of clinical trials. Mr. Fiset holds MBA with honor from Universit? Laval and a Master degree in Microbiology from the University of Sherbrooke.

Positions